4//SEC Filing
Murphy Matthew B. 4
Accession 0001628280-21-015647
CIK 0001808805other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:01 PM ET
Size
5.7 KB
Accession
0001628280-21-015647
Insider Transaction Report
Form 4
Murphy Matthew B.
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14+326,526→ 326,526 totalExercise: $10.10Exp: 2031-06-14→ Common Stock (326,526 underlying)
Footnotes (1)
- [F1]Subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan), 25% of the shares subject to such Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date (as defined below), and the balance of the shares subject to such Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary. The Vesting Commencement Date is April 1, 2021.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001865778
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:01 PM ET
- Size
- 5.7 KB